Bill Commons

NY A 9311

in committee

Designates revenue collected by the opioid excise tax for the New York state drug treatment and public education fund

New York · 2025-2026 Regular Session · lower

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did NY A 9311 pass?

Not yet. NY A 9311 is in committee and has not come to a final vote. Latest recorded action (2026-01-07): REFERRED TO WAYS AND MEANS

What is NY A 9311 about?

Designates all taxes, interest and penalties collected by the opioid excise tax for the New York state drug treatment and public education fund.

Who sponsors NY A 9311?

Dana Levenberg is the primary sponsor of NY A 9311, joined by 2 cosponsors.

Description

Designates all taxes, interest and penalties collected by the opioid excise tax for the New York state drug treatment and public education fund.

Introduced
—
Latest action
2026-01-07 — REFERRED TO WAYS AND MEANS
Bill type
bill
Last updated
—

Sponsors

  • Dana Levenbergprimary
  • Chris Burdickcosponsor
  • Judy Griffincosponsor

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-01-07

    REFERRED TO WAYS AND MEANS

    referral-committee

  2. 2025-12-10

    REFERRED TO WAYS AND MEANS

    referral-committee

Versions

Documents

Votes

Not provided by source.

Related bills

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 9311. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.